SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: mc who wrote (5399)2/10/1998 10:24:00 PM
From: Tunica Albuginea  Read Replies (1) of 23519
 
Gary, Leland will make the 33% up in a jiffy. I don't begrudge or judge other people's good fortune. There is still enough misery for them and all the rest to share in in a lifetime. I like to limit my judgement to my investment: Vivus delivered: major publication in NEJM with $120 mill in sales in 9 months; 2 new factories and one in Ireland planned. Worldwide expansion. In spite of major obstacles and lawsuits. You can say that the execution should have been more perfect: but isn't that too much to ask from a new start? Or that they should have gone into bigger debt built a bigger factory to avoid the product shortage we've had.But what if Vivus had bombed? Better to be a little conservative.The stock gyrations reflect more investor psychology than Vivus' performance as a company.FDA lead feet
also contributed.

TA
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext